Myriad Genetics | MYGN - Себестоимость





Себестоимость Изменить Дата
Agilent USD 852M 19M 2025-12
Becton, Dickinson and Co. USD 2.84B 2.35B 2025-12
Bio-Rad Laboratories USD 309.6M 3.3M 2025-09
Bruker USD 528M 46.9M 2025-12
Danaher USD 2.36B 512M 2026-03
Illumina USD 400M 49M 2025-12
J&J USD 8.07B 103M 2026-03
Mettler Toledo International USD 473.97M 33.71M 2025-12
Myriad Genetics USD 63M 1.1M 2025-12
OraSure Technologies USD 15.43M 113K 2025-12
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Quidel USD 448.8M 1.21B 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Standard Biotools USD 12.41M 2.34M 2025-12
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Veracyte USD 39.28M 1.93M 2025-12
Waters USD 374.94M 47.13M 2025-12